BridgeBio Pharma, Inc. BBIO
Set alert
75.00 USD +0.05 +0.06%
At close · Nov 2
74.25 -0.75 -0.99%
After hours · Nov 2, 7:44 PM ET
74.20 Day range 76.70
61.37 52-week range 90.17
- YTD
- -1.95%
- 1 year
- +19.72%
- Open
- 74.96
- Prev close
- 74.95
- Mkt cap
- 14.61B
- Vol
- 3.10M
- Avg vol
- 2.57M
- EPS
- -3.03
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 74.20
- High
- 76.70
- Forward P/E
- -231.49
- Beta
- 0.94
- Short ratio
- 6.50
- Inst. own
- 99.87%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 23, 2027
- 50-d avg
- 70.27
- 200-d avg
- 72.74
- 1y target
- 107.11
1M chart
Events in this range
- Oct 19, 2026Rating: Piper Sandler · Overweight → Overweight
- Oct 19, 2026Rating: Citigroup · Neutral → Neutral
- Oct 21, 2026Rating: Morgan Stanley · Overweight → Overweight
- Oct 29, 2026Earnings: -0.42; estimate -0.54225; surprise 22.54%
- Oct 30, 2026Rating: Morgan Stanley · Overweight → Overweight
- Oct 30, 2026Rating: TD Cowen · Buy → Buy
- Nov 2, 2026Rating: Canaccord Genuity · Buy → Buy
Signals (6)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 30, 2026 | 3 days ago |
| SMA: Bullish | Oct 28, 2026 | 5 days ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 8, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 6, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 5, 2026 | 4 weeks ago |
Held by funds
170 US ETFs and mutual funds hold BBIO · largest positions
Ownership
Held by insiders 3.93%
Held by institutions 99.87%
Float held by institutions 103.95%
Institutions 655
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Jupiter Topco LLC | 7.24% | 14,110,278 | 1.06B | Jun 29, 2026 |
| Kohlberg Kravis Roberts & Co. L.P. | 6.81% | 13,260,971 | 994.51M | Jun 29, 2026 |
| Farallon Capital Management LLC | 5.51% | 10,743,063 | 805.68M | Jun 29, 2026 |
| Blackrock Inc. | 5.28% | 10,287,156 | 771.49M | Jun 29, 2026 |
| Viking Global Investors, L.P. | 5.11% | 9,949,219 | 746.14M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.05% | 7,898,973 | 592.38M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.87% | 5,600,403 | 420.00M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.07% | 4,039,952 | 302.98M | Jun 29, 2026 |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 1.62% | 3,162,851 | 237.20M | Jul 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.20% | 2,330,329 | 174.76M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.01% | 1,974,544 | 148.08M | Jun 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.00% | 1,942,329 | 145.66M | Sep 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| APULI MARICEL | Officer | Sale | Jul 29, 2026 | 127,401 |
| HOMCY CHARLES J | Director | Stock Award(Grant) | Jun 21, 2026 | 919,876 |
| KKR GENETIC DISORDER L.P. | Beneficial Owner of more than 10% of a Class of Security | Sale | May 11, 2025 | 0 |
| KUMAR NEIL | Chief Executive Officer | Sale | Sep 16, 2026 | 0 |
| MCCORMICK FRANK P. PH.D. | Director | Stock Award(Grant) | Jun 21, 2026 | 767,244 |
| MOMTAZEE JAMES C | Director | Stock Award(Grant) | Jun 21, 2026 | 99,070 |